ArticleScientific reports2026
Myco-synthesized copper oxide nanoparticles as a sustainable bionanofungicide for managing Fusarium falciforme and enhancing potato productivity.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Developing sustainable alternatives to chemical fungicides is imperative for sustainable agriculture. This study establishes a green nanotechnology approach by harnessing the biocatalytic potential of indigenous rhizosphere fungi to synthesize copper oxide nanoparticles (CuONPs). A consortium of soil-borne fungi, including Mucor circinelloides, was isolated from agricultural soils in Tanta, Egypt, and employed in the myco-synthesis of CuONPs. Comprehensive characterization confirmed the formation of crystalline, spherical nanoparticles (average size: 10.7 nm). The nanoparticles exhibited notable, dose-dependent antifungal activity in vitro, suppressing mycelial growth of the potato pathogen Fusarium falciforme by 33.95%, significantly outperforming bulk copper sulfate. Based on preliminary dose-response trials, 200 mg L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.